149 related articles for article (PubMed ID: 10607768)
1. beta(2)-microglobulin kinetics in nocturnal haemodialysis.
Raj DS; Ouwendyk M; Francoeur R; Pierratos A
Nephrol Dial Transplant; 2000 Jan; 15(1):58-64. PubMed ID: 10607768
[TBL] [Abstract][Full Text] [Related]
2. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.
Lornoy W; Becaus I; Billiouw JM; Sierens L; Van Malderen P; D'Haenens P
Nephrol Dial Transplant; 2000; 15 Suppl 1():49-54. PubMed ID: 10737167
[TBL] [Abstract][Full Text] [Related]
3. Residual kidney function in nocturnal vs conventional haemodialysis patients: a prospective observational study.
Skeat L; Masterson R; Tjipto AC; Karschimkus C; Toussaint ND
Int Urol Nephrol; 2020 Apr; 52(4):757-764. PubMed ID: 32124232
[TBL] [Abstract][Full Text] [Related]
4. Validation of a two-pool model for the kinetics of beta2-microglobulin.
Stiller S; Xu XQ; Gruner N; Vienken J; Mann H
Int J Artif Organs; 2002 May; 25(5):411-20. PubMed ID: 12074339
[TBL] [Abstract][Full Text] [Related]
5. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis.
Mucsi I; Hercz G; Uldall R; Ouwendyk M; Francoeur R; Pierratos A
Kidney Int; 1998 May; 53(5):1399-404. PubMed ID: 9573558
[TBL] [Abstract][Full Text] [Related]
6. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
Teruel-Briones JL; Fernández-Lucas M; Rivera-Gorrin M; Ruiz-Roso G; Díaz-Domínguez M; Rodríguez-Mendiola N; Quereda-Rodríguez-Navarro C
Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155
[TBL] [Abstract][Full Text] [Related]
7. Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients.
Stein G; Franke S; Mahiout A; Schneider S; Sperschneider H; Borst S; Vienken J
Nephrol Dial Transplant; 2001 May; 16(5):999-1008. PubMed ID: 11328907
[TBL] [Abstract][Full Text] [Related]
8. Haemodialysis without anticoagulant: haemostasis parameters, fibrinogen kinetic, and dialysis efficiency.
Româo JE; Fadil MA; Sabbaga E; Marcondes M
Nephrol Dial Transplant; 1997 Jan; 12(1):106-10. PubMed ID: 9027783
[TBL] [Abstract][Full Text] [Related]
9. Change from conventional haemodiafiltration to on-line haemodiafiltration.
Maduell F; del Pozo C; Garcia H; Sanchez L; Hdez-Jaras J; Albero MD; Calvo C; Torregrosa I; Navarro V
Nephrol Dial Transplant; 1999 May; 14(5):1202-7. PubMed ID: 10344362
[TBL] [Abstract][Full Text] [Related]
10. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
[TBL] [Abstract][Full Text] [Related]
11. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
Pellicano R; Polkinghorne KR; Kerr PG
Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
[TBL] [Abstract][Full Text] [Related]
12. Diacap alpha-polysulfone HI PS: a new dialysis membrane with optimum beta2-microglobulin elimination.
Mann H; Al-Bashir A; Melzer H; Stiller S
Int J Artif Organs; 2003 Jun; 26(6):461-6. PubMed ID: 12866651
[TBL] [Abstract][Full Text] [Related]
13. Solute kinetics with short-daily home hemodialysis using slow dialysate flow rate.
Kohn OF; Coe FL; Ing TS
Hemodial Int; 2010 Jan; 14(1):39-46. PubMed ID: 19758296
[TBL] [Abstract][Full Text] [Related]
14. Serum beta2-microglobulin and immunoglobulin levels in young hemodialysis patients.
Dixit MP; Cabansag MR; Piscitelli J; Greifer I; Silverstein DM
Pediatr Nephrol; 1999 Feb; 13(2):139-42. PubMed ID: 10229003
[TBL] [Abstract][Full Text] [Related]
15. Rebound kinetics of beta2-microglobulin after hemodialysis.
Leypoldt JK; Cheung AK; Deeter RB
Kidney Int; 1999 Oct; 56(4):1571-7. PubMed ID: 10504510
[TBL] [Abstract][Full Text] [Related]
16. Calcium phosphate metabolism and bone mineral density with nocturnal hemodialysis.
Toussaint N; Boddington J; Simmonds R; Waldron C; Somerville C; Agar J
Hemodial Int; 2006 Jul; 10(3):280-6. PubMed ID: 16805890
[TBL] [Abstract][Full Text] [Related]
17. Daily hemofiltration for end-stage renal disease: a feasibility and efficacy trial.
Jaber BL; Zimmerman DL; Teehan GS; Swedko P; Burns K; Meyer KB; Leypoldt JK
Blood Purif; 2004; 22(6):481-9. PubMed ID: 15523174
[TBL] [Abstract][Full Text] [Related]
18. Review of clinical outcomes in nocturnal haemodialysis patients after renal transplantation.
McCormick BB; Pierratos A; Fenton S; Jain V; Zaltzman J; Chan CT
Nephrol Dial Transplant; 2004 Mar; 19(3):714-9. PubMed ID: 14767030
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
[TBL] [Abstract][Full Text] [Related]
20. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration.
Fry AC; Singh DK; Chandna SM; Farrington K
Blood Purif; 2007; 25(3):295-302. PubMed ID: 17622712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
